Table V.

Allogeneic transplantation outcomes stratified according to transplantation conditioning intensity.

	Myeloablative conditioning Adjusted probability (95% CI)	Reduced-intensity or non- myeloablative conditioning Adjusted probability (95% CI)	p-value
Progression-free survival	N= 126	N=368
1-year	36 (26–44)%	46 (42–51)%	0.03
3-year	29 (21–36)%	33 (28–37)%	0.39
5-year	27 (19–34)%	30 (25–35)%	0.47
Overall survival	N=127	N=376
1-year	44 (36–52)%	56 (52–61)%	0.01
3-year	31 (23–39)%	39 (34–44)%	0.12
5-year	28 (20–36)%	37 (32–42)%	0.055
Chemoresistant patients only
Progression-free survival	N=35	N=69
1-year	16 (4–27)%	33 (23–44)%	0.03
3-year	13 (2–24)%	20 (11–29)%	0.31
5-year	13 (2–24)%	18 (9–27)%	0.47
Overall survival	N=35	N=71
1-year	23 (10–37)%	45 (33–56)%	0.02
3-year	15 (3–27)%	29 (19–39)%	0.09
5-year	15 (3–27)%	25 (15–35)%	0.22